Let's talk medical research

Biliary tract cancer (which includes intrahepatic cholangiocarcinoma or bile duct cancer, extrahepatic cholangiocarcinoma, and gallbladder cancer) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile to the small intestine.

By some estimations, 80% of clinical trials are delayed or closed because researchers can’t find enough patients to take part in their clinical trials. This, of course, means that trial sponsors are losing money and sites are wasting time screening ineligible patients. But, it also means that countless patients continue to wait for new and potentially better treatment options.

As of September 2020, there have been over 30 million COVID-19 cases worldwide, with nearly 7 million cases in the United States alone. The impact of this global pandemic is widespread, ranging from how we conduct ourselves in public to the ways in which we seek healthcare.

Living with myasthenia gravis, a rare neuromuscular disorder characterized by progressive weakness of the skeletal muscles, can be difficult. The symptoms, which include trouble talking, facial paralysis, difficulty breathing due to muscle weakness, fatigue, drooping of eyelids, and double vision, can make those living with the condition feel very isolated.

Living with lupus can be difficult. It’s an “invisible illness” — meaning those around you can’t see your fatigue or your muscle and joint pain or any of the many other symptoms. This can be a lonely experience, and that’s why it’s so important for people with lupus to connect with others who have the condition as well.

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that is generally restricted to the colon, causing long-lasting inflammation and ulcers (sores) in your digestive tract.

Maneuvering clinical trial listings can be a daunting task for any patient. In fact, searching for trials has become more and more difficult over the years, largely due to increasingly stringent eligibility requirements. That’s why we created Antidote Match, the first trial matching engine that uses structured data and proprietary algorithms to explore a patient’s eligibility for every trial.

At Antidote, we receive a lot of questions about participating in a clinical trial.

Clinical trial patient recruitment can take a long time, and 80% of clinical trials today are delayed or closed due to difficulty finding patients to take part. If you have the right recruitment strategies in place for your clinical trial, then enrolling patients doesn’t have to slow your research down.

Sickle cell disease (SCD), a genetic condition presented at birth, is a group of inherited red blood cell disorders. SCD affects millions of people worldwide, and while the exact number of people living with SCD in the U.S. is unknown, it is estimated that it affects approximately 100,000 Americans.